Skip to main content
Year archive

Oncopeptides — 2024 filings

All 53 regulatory filings released by Oncopeptides (ONCO) in 2024, sourced directly from the official regulator.

53 Filings
2024 Period
2024 filings (53)
Filing Released Lang
Oncopeptides obtains reimbursement for Pepaxti in Italy
Regulatory Filings
2024-11-27 English
Oncopeptides erhåller subvention för Pepaxti i Italien
Regulatory Filings
2024-11-27 Swedish
Oncopeptides announces the Nomination Committee
AGM Information
2024-11-22 English
Oncopeptides har utsett valberedningen
Board/Management Information
2024-11-22 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q3 2024
2024-11-07 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q3 2024
2024-11-07 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q2 2024
2024-08-14 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q2 2024
2024-08-14 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-07-11 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-07-05 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-07-02 English
Number of shares and votes in Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2024-06-28 English
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2024-06-28 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-13 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-11 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-11 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-05 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-03 English
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
AGM Information
2024-05-31 English
Kommuniké från årsstämma i Oncopeptides AB (publ)
AGM Information
2024-05-31 Swedish
Number of shares and votes in Oncopeptides
Share Issue/Capital Change
2024-05-31 English
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2024-05-31 Swedish
Oncopeptides emitterar teckningsoptioner för att uppfylla sina skyldigheter under låneavtal med EIB
Capital/Financing Update
2024-05-30 Swedish
Oncopeptides issues warrants to fulfil its obligations under loan agreement with EIB
Share Issue/Capital Change
2024-05-30 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-30 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-30 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-05-23 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-05-21 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-05-17 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-05-16 English
Oncopeptides publishes final outcome in the fully guaranteed rights issue
Capital/Financing Update
2024-05-06 English
Oncopeptides offentliggör slutgiltigt utfall i den fullt garanterade företrädesemissionen
Declaration of Voting Results & Voting Rights Announcements
2024-05-06 Swedish
Årsstämma i Oncopeptides AB (publ)
AGM Information
2024-04-29 Swedish
Annual General Meeting in Oncopeptides AB (publ)
AGM Information
2024-04-29 English
Annual Report (ESEF) 2023
Annual Report (ESEF) FY 2023
2024-04-22 Swedish
Oncopeptides offentliggör prospekt avseende företrädesemissionen
Capital/Financing Update
2024-04-17 Swedish
Oncopeptides publishes prospectus relating to the rights issue
Capital/Financing Update
2024-04-17 English
Bulletin from an Extraordinary General Meeting in Oncopeptides AB (publ)
AGM Information
2024-04-15 English
Kommuniké från Extra Bolagsstämma i Oncopeptides AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2024-04-15 Swedish
Oncopeptides announces final terms for the fully guaranteed rights issue
Capital/Financing Update
2024-04-08 English
Oncopeptides offentliggör slutliga villkor för den fullt garanterade företrädesemissionen
Share Issue/Capital Change
2024-04-08 Swedish
Oncopeptides releases first quarter 2024 sales
Earnings Release Q1 2024
2024-04-04 English
Oncopeptides offentliggör försäljning för första kvartalet 2024
Earnings Release Q1 2024
2024-04-04 Swedish
Extraordinary General Meeting in Oncopeptides AB (publ)
AGM Information
2024-03-13 English
Extra bolagsstämma i Oncopeptides AB (publ)
AGM Information
2024-03-13 Swedish
Oncopeptides genomför en fullt garanterad företrädesemission om cirka 300 miljoner kronor för att nå lönsamhet under 2026
Capital/Financing Update
2024-03-13 Swedish
Oncopeptides carries out a fully guaranteed rights issue of approximately SEK 300 million to reach profitability during 2026
Capital/Financing Update
2024-03-13 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q4 2023
2024-02-27 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q4 2023
2024-02-27 English
Oncopeptides receives positive recommendation for Pepaxti by Spanish Pricing Authority
Regulatory Filings
2024-02-23 English
Oncopeptides får positiv rekommendation av Pepaxti från den spanska prismyndigheten
Regulatory Filings
2024-02-23 Swedish
Oncopeptides ensures five years extended market exclusivity for Pepaxti in Europe
Regulatory Filings
2024-02-15 English
Oncopeptides säkerställer förlängd marknadsexklusivitet för Pepaxti i Europa med fem år
Regulatory Filings
2024-02-15 Swedish